EMILY MASSEY: Open Payments
NPI 1588079248 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 22 payments from 12 companies in 2025. Trend: 2023 $717 · 2024 $756 · 2025 $608
Food & beverage: $576Education: $32
| Company | Payments | Amount |
|---|---|---|
| One Lambda, Inc. | 1 | $210 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Vantive US Healthcare LLC | 1 | $31 |
| OPKO Pharmaceuticals, LLC | 1 | $29 |
| SCPHARMACEUTICALS INC. | 1 | $27 |
| Fresenius USA Marketing, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $18 |
Products named: Fabhalta, FARXIGA, Vanrafia, Renal - CRRT, RAYALDEE, FUROSCIX, VELPHORO, JARDIANCE.
Industry payments across GA — which companies pay providers there.
